JCI - Citations to Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.

Citations to this article

Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.

L W Castellani, … , A M Fogelman, A J Lusis

L W Castellani, … , A M Fogelman, A J Lusis

Published July 15, 1997
Citation Information: J Clin Invest. 1997;100(2):464-474. https://doi.org/10.1172/JCI119554.

View: Text | PDF

Research Article

Total citations by year

Year:	2024	2023	2022	2021	2020	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	Total
Citations:	1	2	3	4	1	2	2	1	2	3	3	4	7	5	1	5	7	8	4	5	4	8	14	16	11	6	129

Citation information

Citations to this article (129)

Title and authors	Publication	Year
Divergent Roles of APOAI and APOM in the Identification of Alcohol Use Disorder and Their Association With Inflammation and Cognitive Decline: A Pilot Study Escudero B, López-Valencia L, Arias Horcajadas F, Orio L	The International Journal of Neuropsychopharmacology	2024
Proteomic Profiling of Extracellular Vesicles Isolated from Plasma and Peritoneal Exudate in Mice Induced by Crotalus scutulatus scutulatus Crude Venom and Its Purified Cysteine-Rich Secretory Protein (Css-CRiSP) Reyes A, Hatcher JD, Salazar E, Galan J, Iliuk A, Sanchez EE, Suntravat M	Toxins	2023
Dyslipidemia in rheumatoid arthritis: the possible mechanisms Yan J, Yang S, Han L, Ba X, Shen P, Lin W, Li T, Zhang R, Huang Y, Huang Y, Qin K, Wang Y, Tu S, Chen Z	Frontiers in immunology	2023
Alterations of HDL's to piHDL's Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies. Vyletelová V, Nováková M, Pašková Ľ	Pharmaceuticals (Basel, Switzerland)	2022
Apolipoprotein A-II, a Player in Multiple Processes and Diseases. Florea G, Tudorache IF, Fuior EV, Ionita R, Dumitrescu M, Fenyo IM, Bivol VG, Gafencu AV	Biomedicines	2022
HDL-apoA-II Is Strongly Associated with 1-Year Mortality in Acute Heart Failure Patients. Klobučar I, Degoricija V, Potočnjak I, Trbušić M, Pregartner G, Berghold A, Fritz-Petrin E, Habisch H, Madl T, Frank S	Biomedicines	2022
Current Understanding of the Immunomodulatory Activities of High-Density Lipoproteins A Trakaki, G Marsche	Biomedicines	2021
Interaction between Apo A-II -265T>C polymorphism and dietary total antioxidant capacity on some anthropometric indices and serum lipid profile in patients with type 2 diabetes mellitus Jafari Azad B, Yaseri M, Daneshzad E, Koohdani F	Journal of Nutritional Science	2021
Biological anti-psoriatic therapy profoundly affects high-density lipoprotein function A Trakaki, P Wolf, W Weger, TO Eichmann, H Scharnagl, JT Stadler, W Salmhofer, E Knuplez, M Holzer, G Marsche	Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids	2021
Interaction between Apo A-II –265T > C polymorphism and dietary total antioxidant capacity on some oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus BJ Azad, M Yaseri, E Daneshzad, F Koohdani	British Journal of Nutrition	2021
High‐density lipoprotein‐related cholesterol metabolism in Alzheimer’s disease S Pedrini, P Chatterjee, E Hone, RN Martins	Journal of Neurochemistry	2020
Apolipoprotein A-II induces acute-phase response associated AA amyloidosis in mice through conformational changes of plasma lipoprotein structure M Yang, Y Liu, J Dai, L Li, X Ding, Z Xu, M Mori, H Miyahara, J Sawashita, K Higuchi	Scientific Reports	2018
Difference in the Vitreal Protein Profiles of Patients with Proliferative Diabetic Retinopathy with and without Intravitreal Conbercept Injection C Zou, M Zhao, J Yu, D Zhu, Y Wang, X She, Y Hu, Z Zheng	Journal of Ophthalmology	2018
Caloric restriction reduces the systemic progression of mouse AApoAII amyloidosis L Li, J Sawashita, X Ding, M Yang, Z Xu, H Miyahara, M Mori, K Higuchi, A Cignarella	PloS one	2017
Placental Proteomics Provides Insights into Pathophysiology of Pre-Eclampsia and Predicts Possible Markers in Plasma S Mary, MJ Kulkarni, D Malakar, SR Joshi, SS Mehendale, AP Giri	Journal of Proteome Research	2017
APO A2 -265T /C Polymorphism Is Associated with Increased Inflammatory Responses in Patients with Type 2 Diabetes Mellitus F Koohdani, H Sadrzadeh-Yeganeh, M Djalali, M Eshraghian, E Zamani, G Sotoudeh, MA Mansournia, L Keramat	Diabetes & Metabolism Journal	2016
The cholesterol transporter ABCG1 links cholesterol homeostasis and tumour immunity D Sag, C Cekic, R Wu, J Linden, CC Hedrick	Nature Communications	2015
Serum levels of free T3 are associated with ApoA1 and ApoA2, whereas free T4 levels are associated with ApoB and LDL-cholesterol in euthyroid cardiovascular patients H Takeuchi	IJC Metabolic & Endocrine	2015
Association of pro-inflammatory high-density lipoprotein cholesterol with clinical and laboratory variables in sickle cell disease KI Ataga, A Hinderliter, JE Brittain, S Jones, H Xu, J Cai, S Kim, KA Pritchard, CA Hillery	Hematology	2014
Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis DM Shih, Z Wang, R Lee, Y Meng, N Che, S Charugundla, H Qi, J Wu, C Pan, JM Brown, T Vallim, BJ Bennett, M Graham, SL Hazen, AJ Lusis	Journal of lipid research	2014
A High Throughput Biochemical Fluorometric Method for Measuring Lipid Peroxidation in HDL T Kelesidis, CK Roberts, D Huynh, O Martínez-Maza, JS Currier, ST Reddy, OO Yang, P Mukhopadhyay		2014
Human Apolipoprotein A-II Protects Against Diet-Induced Atherosclerosis in Transgenic Rabbits Y Wang, M Niimi, K Nishijima, AB Waqar, Y Yu, T Koike, S Kitajima, E Liu, T Inoue, M Kohashi, Y Keyamura, T Yoshikawa, J Zhang, L Ma, X Zha, T Watanabe, Y Asada, YE Chen, J Fan	Arteriosclerosis, thrombosis, and vascular biology	2013
Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transport J Julve, JC Escolà-Gil, E Rodríguez-Millán, JM Martín-Campos, M Jauhiainen, H Quesada, IM Rentería-Obregón, J Osada, JL Sánchez-Quesada, F Blanco-Vaca	Molecular Nutrition & Food Research	2013
Paraoxonase-1 Suppresses Experimental Colitis via the Inhibition of IFN- Production from CD4 T Cells J Yamashita, C Iwamura, T Ito, M Narita, Y Hara, T Sasaki, D Masuda, M Takahashi, M Tsuchiya, K Hada, M Ishikawa, T Matsuo, Y Ohno, H Tanaka, H Maruyama, Y Ogawa, T Nakayama	Journal of immunology (Baltimore, Md. : 1950)	2013
High yield expression and purification of recombinant human apolipoprotein A-II in Escherichia coli LE Smith, J Yang, L Goodman, X Huang, R Huang, J Dressman, J Morris, RA Silva, WS Davidson, G Cavigiolio	Journal of lipid research	2012
Genetics of Atherosclerosis AJ Lusis	Trends in genetics : TIG	2012
High yield expression and purification of recombinant human apolipoprotein A-II in Escherichia coli LE Smith, J Yang, L Goodman, X Huang, R Huang, J Dressman, J Morris, RA Silva, WS Davidson, G Cavigiolio	Journal of lipid research	2012
Apolipoprotein A-II Influences Apolipoprotein E-Linked Cardiovascular Disease Risk in Women with High Levels of HDL Cholesterol and C-Reactive Protein JP Corsetti, SJ Bakker, CE Sparks, RP Dullaart, A Scuteri	PloS one	2012
Apolipoprotein A-II suppressed concanavalin A-induced hepatitis via the inhibition of CD4 T cell function J Yamashita, C Iwamura, T Sasaki, K Mitsumori, K Ohshima, K Hada, N Hara, M Takahashi, Y Kaneshiro, H Tanaka, K Kaneko, T Nakayama	Journal of immunology (Baltimore, Md. : 1950)	2011
Genetics and molecular biology J Pétremand, C Widmann	Current Opinion in Lipidology	2011
Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk A Onat, G Hergenç	Metabolism	2011
HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress SP Deakin, S Bioletto, ML Bochaton-Piallat, RW James	Free radical biology & medicine	2011
Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis PD Kirk, A Witkover, A Courtney, AM Lewin, R Wait, MP Stumpf, S Richardson, GP Taylor, CR Bangham	Retrovirology	2011
ApoA-I deficiency in mice is associated with redistribution of apoA-II and aggravated AApoAII amyloidosis Y Wang, J Sawashita, J Qian, B Zhang, X Fu, G Tian, L Chen, M Mori, K Higuchi	Journal of lipid research	2011
Clinical role of apolipoproteins A and B GA Chumakova, OV Gritsenko, NG Veselovskaya, EV Vakhromeeva, AA Kozarenko		2011
Myeloperoxidase, Inflammation, and Dysfunctional HDL JD Smith	Journal of Clinical Lipidology	2010
Dysfunctional HDL as a Diagnostic and Therapeutic Target JD Smith	Arteriosclerosis, thrombosis, and vascular biology	2010
Molecular Biology of Atherosclerosis IK Jeong	Endocrinology and Metabolism	2010
The HDL Handbook NJ Hime	The HDL Handbook	2010
HDL: More Than Just Cholesterol A Meilina, A Wijaya	The Indonesian Biomedical Journal	2010
In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection JC Escolà-Gil, N Rotllan, J Julve, F Blanco-Vaca	Atherosclerosis	2009
Determinants of variation in human serum paraoxonase activity DL Rainwater, S Rutherford, TD Dyer, ED Rainwater, SA Cole, JL Vandeberg, L Almasy, J Blangero, JW Maccluer, MC Mahaney	Heredity	2008
The apolipoprotein AII rs5082 variant is associated with reduced risk of coronary artery disease in an Australian male population J Xiao, F Zhang, S Wiltshire, J Hung, M Jennens, JP Beilby, PL Thompson, BM McQuillan, PA McCaskie, KW Carter, LJ Palmer, BL Powell	Atherosclerosis	2008
Apolipoprotein A-II augments monocyte responses to LPS by suppressing the inhibitory activity of LPS-binding protein PA Thompson, JF Berbée, PC Rensen, RL Kitchens	Innate immunity	2008
The plasma concentration of Lpa-I:A-II particles as a predictor of the inflammatory response in patients with ST-elevation myocardial infarction M Gomaraschi, G Sinagra, LV Serdoz, C Pitzorno, M Fonda, L Cattin, L Calabresi, G Franceschini	Atherosclerosis	2008
HDL subfraction distribution of paraoxonase-1 and its relevance to enzyme activity and resistance to oxidative stress X Moren, S Deakin, ML Liu, MR Taskinen, RW James	Journal of lipid research	2008
Apolipoprotein AII Is a Regulator of Very Low Density Lipoprotein Metabolism and Insulin Resistance LW Castellani, CN Nguyen, S Charugundla, MM Weinstein, CX Doan, WS Blaner, N Wongsiriroj, AJ Lusis	The Journal of biological chemistry	2007
Is Elevated High-density Lipoprotein Cholesterol Always Good for Coronary Heart Disease? Y Sun, Y Yang, W Pei, Y Wu, J Zhao	Clinical Cardiology	2007
Pharmacogenetic interaction between paraoxonase-1 gene promoter polymorphism C-107T and statin S Deakin, S Guernier, RW James	Pharmacogenetics and Genomics	2007
The Structure of Apolipoprotein A-II in Discoidal High Density Lipoproteins RA Silva, LA Schneeweis, SC Krishnan, X Zhang, PH Axelsen, WS Davidson	The Journal of biological chemistry	2007
An Apolipoprotein A-II Polymorphism (-265T/C, rs5082) Regulates Postprandial Response to a Saturated Fat Overload in Healthy Men J Delgado-Lista, F Perez-Jimenez, T Tanaka, P Perez-Martinez, Y Jimenez-Gomez, C Marin, J Ruano, L Parnell, JM Ordovas, J Lopez-Miranda	The Journal of nutrition	2007
High‐Density Lipoproteins: From Basic Biology to Clinical Aspects CJ Fielding		2007
The −256T>C Polymorphism in the Apolipoprotein A-II Gene Promoter Is Associated with Body Mass Index and Food Intake in the Genetics of Lipid Lowering Drugs and Diet Network Study D Corella, DK Arnett, MY Tsai, EK Kabagambe, JM Peacock, JE Hixson, RJ Straka, M Province, CQ Lai, LD Parnell, I Borecki, JM Ordovas	Clinical chemistry	2007
Clinical aspects of plasma platelet-activating factor-acetylhydrolase K Karasawa	Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids	2006
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis A Kontush, MJ Chapman	Pharmacological reviews	2006
High-density lipoproteins: an emerging target in the prevention of cardiovascular disease BA Cutri, NJ Hime, SJ Nicholls	Cell Research	2006
Análisis del proteoma hepático de ratones transgénicos de apo A-II humana: identificación de proteínas potencialmente implicadas en la regulación del metabolismo de triglicéridos y la respuesta a la insulina N Rotllan, S Süren-Castillo, V Ribas, X Palomer, L Calpe-Berdiel, E Zapico, N Roglans, J Julve, JC Laguna, F Blanco-Vaca, JC Escolà-Gil	Clínica e Investigación en Arteriosclerosis	2006
Trypanosoma congolense: Paraoxonase 1 prolongs survival of infected mice KK Bhasin, JM Yu, A Tward, D Shih, DA Campbell, AJ Lusis	Experimental Parasitology	2006
ApoA-I Mimetic Peptides with Differing Ability to Inhibit Atherosclerosis Also Exhibit Differences in Their Interactions with Membrane Bilayers SP Handattu, DW Garber, DC Horn, DW Hughes, B Berno, AD Bain, VK Mishra, MN Palgunachari, G Datta, GM Anantharamaiah, RM Epand	The Journal of biological chemistry	2006
Trans-10, cis-12- and cis-9, trans-11-Conjugated Linoleic Acid Isomers Selectively Modify HDL-Apolipoprotein Composition in Apolipoprotein E Knockout Mice JM Arbonés-Mainar, MA Navarro, S Acín, MA Guzmán, C Arnal, JC Surra, R Carnicer, HM Roche, J Osada	The Journal of nutrition	2006
Overexpression of Lysosomal Acid Lipase and Other Proteins in Atherosclerosis O Zschenker, T Illies, D Ameis	Journal of Biochemistry	2006
Dyslipidemia and inflammation: an evolutionary conserved mechanism E Esteve, W Ricart, JM Fernández-Real	Clinical Nutrition	2005
Lipoprotein Composition in Children and Adolescents with Type 1 Diabetes Mellitus P Bustos, C Radojkovic, N Ulloa, M Muñoz, A Martinez, C Calvo, S Asenjo	Journal of Pediatric Endocrinology and Metabolism	2005
Tyrosine Modification Is Not Required for Myeloperoxidase-induced Loss of Apolipoprotein A-I Functional Activities DQ Peng, Z Wu, G Brubaker, L Zheng, M Settle, E Gross, M Kinter, SL Hazen, JD Smith	The Journal of biological chemistry	2005
High Affinity, Stability, and Lactonase Activity of Serum Paraoxonase PON1 Anchored on HDL with ApoA-I L Gaidukov, DS Tawfik	Biochemistry	2005
Reciprocal hemizygosity analysis of mouse hepatic lipase reveals influence on obesity P Farahani, JS Fisler, H Wong, AL Diament, N Yi, CH Warden	Obesity research	2004
The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity RW James, SP Deakin	Free radical biology & medicine	2004
Characterization of epistasis influencing complex spontaneous obesity in the BSB model N Yi, A Diament, S Chiu, K Kim, DB Allison, JS Fisler, CH Warden	Genetics	2004
Sequence of horse (Equus caballus) apoA-II. Another example of a dimer forming apolipoprotein DL Puppione, WH Fischer, M Park, JP Whitelegge, VN Schumaker, S Golfeiz, MH MacDonald	Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology	2004
Mechanisms mediating insulin resistance in transgenic mice overexpressing mouse apolipoprotein A-II LW Castellani, P Gargalovic, M Febbraio, S Charugundla, ML Jien, AJ Lusis	Journal of lipid research	2004
Apolipoprotein A-II: beyond genetic associations with lipid disorders and insulin resistance AD Kalopissis, D Pastier, J Chambaz	Current Opinion in Lipidology	2003
Functional Genomics of the Paraoxonase (PON1) Polymorphisms: Effects on Pesticide Sensitivity, Cardiovascular Disease, and Drug Metabolism LG Costa, TB Cole, GP Jarvik, CE Furlong	Annual Review of Medicine	2003
Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor S Deakin, I Leviev, MC Brulhart-Meynet, RW James	Biochemical Journal	2003
Identification of paraoxonase 3 in rat liver microsomes: purification and biochemical properties L Rodrigo, F Gil, AF Hernandez, O Lopez, A Pla	Biochemical Journal	2003
Wiley Encyclopedia of Molecular Medicine WT Morgan	Wiley Encyclopedia of Molecular Medicine	2002
Apolipoproteins A-I and A-II downregulate neutrophil functions CJ Furlaneto, FP Ribeiro, E Hatanaka, GM Souza, MA Cassatella, A Campa	Lipids	2002
Apolipoprotein A-II, HDL metabolism and atherosclerosis A Tailleux, P Duriez, JC Fruchart, V Clavey	Atherosclerosis	2002
Paraoxonase 1 Overexpression in Mice and Its Effect on High-Density Lipoproteins MN Oda, JK Bielicki, TT Ho, T Berger, EM Rubin, TM Forte	Biochemical and Biophysical Research Communications	2002
Upregulation of collagens detected by gene array in a model of flow-induced pulmonary vascular remodeling M Medhora, M Bousamra, D Zhu, L Somberg, ER Jacobs	American journal of physiology. Heart and circulatory physiology	2002
Paraoxonase (PON1) in Health and Disease LG Costa, CE Furlong		2002
Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II E Boisfer, D Stengel, D Pastier, PM Laplaud, N Dousset, E Ninio, AD Kalopissis	Journal of lipid research	2002
ApoA-IMALLORCA impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia JM Martín-Campos, J Julve, JC Escolà, J Ordóñez-Llanos, J Gómez, J Binimelis, F González-Sastre, F Blanco-Vaca	Journal of lipid research	2002
Gemfibrozil treatment potentiates oxidative resistance of high-density lipoprotein in hypertriglyceridemic patients MF Chen, TD Wang, HT Yeh, HC Hsu, YT Lee	European Journal of Clinical Investigation	2001
Mitogenic Effect of Lipoproteins on Human Vascular Smooth Muscle Cells: The Impact of Hydrolysis by gr II A Phospholipase A2 W Pruzanski, E Stefanski, J Kopilov, A Kuksis	Laboratory Investigation	2001
Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs M Sentí, M Tomás, J Marrugat, R Elosua,	Arteriosclerosis, thrombosis, and vascular biology	2001
Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance LW Castellani, AM Goto, AJ Lusis	Diabetes	2001
A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids M Navab, SY Hama, GP Hough, G Subbanagounder, ST Reddy, AM Fogelman	Journal of lipid research	2001
Arg123-Tyr166 domain of human ApoA-I is critical for HDL-mediated inhibition of macrophage homing and early atherosclerosis in mice P Holvoet, K Peeters, S Lund-Katz, A Mertens, P Verhamme, R Quarck, D Stengel, M Lox, E Deridder, H Bernar, M Nickel, G Theilmeier, E Ninio, MC Phillips	Arteriosclerosis, thrombosis, and vascular biology	2001
Lipid predictors of coronary heart disease and tibolone users D Crook	European Heart Journal Supplements	2001
Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I PK Shah, S Kaul, J Nilsson, B Cercek	Circulation	2001
Exploiting the Vascular Protective Effects of High-Density Lipoprotein and its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part II PK Shah, S Kaul, J Nilsson, B Cercek	Circulation	2001
HDL and the Inflammatory Response Induced by LDL-Derived Oxidized Phospholipids M Navab, JA Berliner, G Subbanagounder, S Hama, AJ Lusis, LW Castellani, S Reddy, D Shih, W Shi, AD Watson, BJ Lenten, D Vora, AM Fogelman	Arteriosclerosis, thrombosis, and vascular biology	2001
ApoA-II Versus ApoA-I: Two for One Is Not Always a Good Deal LW Castellani, AJ Lusis	Arteriosclerosis, thrombosis, and vascular biology	2001
In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions CC Hedrick, LW Castellani, H Wong, AJ Lusis	Journal of lipid research	2001
Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations I Leviev, S Deakin, RW James	Journal of lipid research	2001
Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein F Blanco-Vaca, JC Escolà-Gil, JM Martín-Campos, J Julve	Journal of lipid research	2001
Albumin inhibits apolipoprotein AI and AII production in human hepatoblastoma cell line (Hep G2): additive effects of oleate–albumin complex T Sakai, FY Jin, VS Kamanna, ML Kashyap	Atherosclerosis	2000
Responses to eating: lipoproteins, lipolytic products and atherosclerosis IJ Goldberg, Y Kako, EP Lutz	Current Opinion in Lipidology	2000
Les animaux génétiquement modifiésÉtude du transport des lipides et de l'athérosclérose N Baroukh, L Vergnes, M Aostos, M Mzakin, A Ochoa	Annales de l'Institut Pasteur/Actualités	2000
Increased production of very-low-density lipoproteins in transgenic mice overexpressing human apolipoprotein A-II and fed with a high-fat diet J Julve, JC Escolà-Gil, À Marzal-Casacuberta, J Ordóñez-Llanos, F González-Sastre, F Blanco-Vaca	Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids	2000
Infection and Inflammation‐Induced Proatherogenic Changes of Lipoproteins W Khovidhunkit, RA Memon, KR Feingold, C Grunfeld	The Journal of Infectious Diseases	2000
Comparison of Laboratory Parameters as Risk Factors for the Presence and the Extent of Coronary or Carotid Atherosclerosis: the Significance of Apolipoprotein B to Apolipoprotein AII Ratio D Cerne, G Ledinski, G Kager, J Greilberger, X Wang, G Jürgens	Clinical Chemistry and Laboratory Medicine	2000
Wild Type ApoA-II Gene Does Not Rescue Senescence-Accelerated Mouse (SAMP1) From Short Life Span and Accelerated Mortality J Wang, T Matsushita, K Kogishi, C Xia, A Ohta, T Chiba, A Nakamura, H Kondo, M Mori, M Hosokawa, K Higuchi	The Journals of Gerontology Series A: Biological Sciences and Medical Sciences	2000
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3 M Navab, SY Hama, GM Anantharamaiah, K Hassan, GP Hough, AD Watson, ST Reddy, A Sevanian, GC Fonarow, AM Fogelman	Journal of lipid research	2000
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1 M Navab, SY Hama, CJ Cooke, GM Anantharamaiah, M Chaddha, L Jin, G Subbanagounder, KF Faull, ST Reddy, NE Miller, AM Fogelman	Journal of lipid research	2000
Genetic polymorphism in paraoxonase is a risk factor for childhood focal segmental glomerulosclerosis Y Frishberg, H Toledano, R Becker-Cohen, E Feigin, D Halle	American Journal of Kidney Diseases	2000
Heat Shock Protein 60 Is a High-Affinity High-Density Lipoprotein Binding Protein AV Bocharov, TG Vishnyakova, IN Baranova, AT Remaley, AP Patterson, TL Eggerman	Biochemical and Biophysical Research Communications	2000
Infection and Inflammation Induce LDL Oxidation In Vivo RA Memon, I Staprans, M Noor, WM Holleran, Y Uchida, AH Moser, KR Feingold, C Grunfeld	Arteriosclerosis, thrombosis, and vascular biology	2000
Effect of Overexpression of Human Apo A-I in C57BL/6 and C57BL/6 Apo E–Deficient Mice on 2 Lipoprotein-Associated Enzymes, Platelet-Activating Factor Acetylhydrolase and Paraoxonase: Comparison of Adenovirus-Mediated Human Apo A-I Gene Transfer and Human Apo A-I Transgenesis BD Geest, D Stengel, M Landeloos, M Lox, LL Gat, D Collen, P Holvoet, E Ninio	Arteriosclerosis, thrombosis, and vascular biology	2000
Decreased Susceptibility to Diet-Induced Atherosclerosis in Human Apolipoprotein A-II Transgenic Mice A Tailleux, M Bouly, G Luc, G Castro, JM Caillaud, N Hennuyer, P Poulain, JC Fruchart, N Duverger, C Fiévet	Arteriosclerosis, thrombosis, and vascular biology	2000
Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia JC Escolà-Gil, J Julve, À Marzal-Casacuberta, J Ordóñez-Llanos, F González-Sastre, F Blanco-Vaca	Journal of lipid research	2000
Genetic control of HDL levels and composition in an interspecific mouse cross (CAST/Ei × C57BL/6J) M Mehrabian, LW Castellani, PZ Wen, J Wong, T Rithaporn, SY Hama, GP Hough, D Johnson, JJ Albers, GA Mottino, JS Frank, M Navab, AM Fogelman, AJ Lusis	Journal of lipid research	2000
High Density Lipoproteins (HDL) and the Oxidative Hypothesis of Atherosclerosis D Bonnefont-Rousselot, P Thérond, JL Beaudeux, J Peynet, A Le-grand, J Delattre	Clinical Chemistry and Laboratory Medicine	1999
Atheroprotective mechanisms of HDL O Stein, Y Stein	Atherosclerosis	1999
High apolipoprotein AI concentrations are associated with lower mortality and myocardial infarction five years after coronary artery bypass graft surgery JS Skinner, M Farrer, CJ Albers, HA Neil, PC Adams	Heart (British Cardiac Society)	1999
Isolation and complete covalent structure of liver microsomal paraoxonase J Ozols	Biochemical Journal	1999
High-density lipoprotein subclasses and apolipoprotein A-I P Duriez, JC Fruchart	Clinica Chimica Acta	1999
Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis E Boisfer, G Lambert, V Atger, NQ Tran, D Pastier, C Benetollo, JF Trottier, I Beaucamps, M Antonucci, M Laplaud, S Griglio, J Chambaz, AD Kalopissis	The Journal of biological chemistry	1999
Genetic background determines the extent of atherosclerosis in ApoE-deficient mice HM Dansky, SA Charlton, JL Sikes, SC Heath, R Simantov, LF Levin, P Shu, KJ Moore, JL Breslow, JD Smith	Arteriosclerosis, thrombosis, and vascular biology	1999
Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2 B Ivandic, L W Castellani, X P Wang, J H Qiao, M Mehrabian, M Navab, A M Fogelman, D S Grass, M E Swanson, M C de Beer, F de Beer, A J Lusis	Arteriosclerosis, thrombosis, and vascular biology	1999
Low serum paraoxonase: a risk factor for atherosclerotic disease? M I Mackness, P N Durrington, A Ayub, B Mackness	Chemico-Biological Interactions	1999
SREBP-1 Binds to Multiple Sites and Transactivates the Human ApoA-II Promoter In Vitro: SREBP-1 Mutants Defective in DNA Binding or Transcriptional Activation Repress ApoA-II Promoter Activity P Pissios, HY Kan, S Nagaoka, VI Zannis	Arteriosclerosis, thrombosis, and vascular biology	1999
Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q→R genetic polymorphism H Cao, A Girard-Globa, F Berthezene, P Moulin	Journal of lipid research	1999
Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response KR Feingold, RA Memon, AH Moser, C Grunfeld	Atherosclerosis	1998
Atherosclerosis: cell biology and lipoproteins KW Wahle	Current Opinion in Lipidology	1998
Lack of Protection against Oxidative Modification of LDL by Avian HDL B Mackness, PN Durrington, MI Mackness	Biochemical and Biophysical Research Communications	1998
Age-related increased susceptibility of high-density lipoproteins (HDL) to in vitro oxidation induced by γ-radiolysis of water A Khalil, JP Jay-Gerin, T Fülöp	FEBS Letters	1998
Paraoxonase PON1 Polymorphism Leu-Met54 Is Associated With Carotid Atherosclerosis: Results of the Austrian Stroke Prevention Study H Schmidt, R Schmidt, K Niederkorn, A Gradert, M Schumacher, N Watzinger, HP Hartung, GM Kostner	Stroke; a journal of cerebral circulation	1998
Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet JC Escolà-Gil, À Marzal-Casacuberta, J Julve-Gil, BY Ishida, J Ordóñez-Llanos, L Chan, F González-Sastre, F Blanco-Vaca	Journal of lipid research	1998

Advertisement